Antimicrobial agents, diagnostic reagents, and vaccines based on unique apicomplexan parasite components

Rima McLeod (Inventor), Craig Roberts (Inventor), Fiona Roberts (Inventor), Jennifer Johnson (Inventor), Michael Kirisits (Inventor), David Ferguson (Inventor), Russell Lyons (Inventor), Ernest Mui (Inventor), Doug Mack (Inventor), Benjamin Samuel (Inventor), Piotri Gornicki (Inventor), Ellen Zuther (Inventor)

Research output: Patent

Abstract

This invention relates uses of components of plant-like metabolic pathways not including psbA or PPi phosphofructokinase and not generally operative in animals or encoded by the plastid DNA, to develop compositions that interfere with Apicomplexan growth and survival. Components of the pathways include enzymes, transit peptides and nucleotide sequences encoding the enzymes and peptides, or promoters of these nucleotide sequences to which antibodies, antisense molecules and other inhibitors are directed. Diagnostic and therapeutic reagents and vaccines are developed based on the components and their inhibitors.
Original languageEnglish
Patent numberUS 20050142113 A1
Priority date4/05/99
Publication statusPublished - 30 Jun 2005

Keywords

  • metabolic pathways
  • Apicomplexan growth
  • inhibitor
  • enzymes
  • vaccines

Cite this

McLeod, R., Roberts, C., Roberts, F., Johnson, J., Kirisits, M., Ferguson, D., Lyons, R., Mui, E., Mack, D., Samuel, B., Gornicki, P., & Zuther, E. (2005). Antimicrobial agents, diagnostic reagents, and vaccines based on unique apicomplexan parasite components. (Patent No. US 20050142113 A1).